262 related articles for article (PubMed ID: 27634860)
1. Treatment of T cell lymphoma in dogs.
Moore AS
Vet Rec; 2016 Sep; 179(11):277. PubMed ID: 27634860
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric characterization and clinical outcome of CD4+ T-cell lymphoma in dogs: 67 cases.
Avery PR; Burton J; Bromberek JL; Seelig DM; Elmslie R; Correa S; Ehrhart EJ; Morley PS; Avery AC
J Vet Intern Med; 2014; 28(2):538-46. PubMed ID: 24495161
[TBL] [Abstract][Full Text] [Related]
3. Treatment of canine non-indolent T cell lymphoma using the VELCAP-TSC protocol: A retrospective evaluation of 70 dogs (2003-2013).
Goodman IH; Moore AS; Frimberger AE
Vet J; 2016 May; 211():39-44. PubMed ID: 27017053
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological characteristics and prognostic factors for canine multicentric non-indolent T-cell lymphoma: 107 cases.
Purzycka K; Peters LM; Desmas I; Davies O; Chang YM; Lara-Garcia A
Vet Comp Oncol; 2020 Dec; 18(4):656-663. PubMed ID: 32163214
[TBL] [Abstract][Full Text] [Related]
5. CHOP chemotherapy for the treatment of canine multicentric T-cell lymphoma.
Rebhun RB; Kent MS; Borrofka SA; Frazier S; Skorupski K; Rodriguez CO
Vet Comp Oncol; 2011 Mar; 9(1):38-44. PubMed ID: 21303452
[TBL] [Abstract][Full Text] [Related]
6. Expression of Apoptosis-regulating Proteins Bcl-2 and Bax in Lymph Node Aspirates from Dogs with Lymphoma.
Meichner K; Fogle JE; English L; Suter SE
J Vet Intern Med; 2016 May; 30(3):819-26. PubMed ID: 27013187
[TBL] [Abstract][Full Text] [Related]
7. Canine indolent and aggressive lymphoma: clinical spectrum with histologic correlation.
Aresu L; Martini V; Rossi F; Vignoli M; Sampaolo M; Aricò A; Laganga P; Pierini A; Frayssinet P; Mantovani R; Marconato L
Vet Comp Oncol; 2015 Dec; 13(4):348-62. PubMed ID: 23782432
[TBL] [Abstract][Full Text] [Related]
8. Prognostic indicators for naïve canine non-indolent T-cell lymphoma treated with combination lomustine, vincristine, procarbazine and prednisolone chemotherapy.
Blaxill J; Buzzacott P; Finlay J
Vet Comp Oncol; 2022 Mar; 20(1):215-226. PubMed ID: 34464024
[TBL] [Abstract][Full Text] [Related]
9. Canine lymphomas: association of classification type, disease stage, tumor subtype, mitotic rate, and treatment with survival.
Valli VE; Kass PH; San Myint M; Scott F
Vet Pathol; 2013 Sep; 50(5):738-48. PubMed ID: 23444036
[TBL] [Abstract][Full Text] [Related]
10. Clinical features of canine nodal T-cell lymphomas classified as CD8+ or CD4-CD8- by flow cytometry.
Harris LJ; Rout ED; Labadie JD; Avery PR; Fernandez M; Yoshimoto J; Avery AC
Vet Comp Oncol; 2020 Sep; 18(3):416-427. PubMed ID: 31951040
[TBL] [Abstract][Full Text] [Related]
11. Hepatosplenic and hepatocytotropic T-cell lymphoma: two distinct types of T-cell lymphoma in dogs.
Keller SM; Vernau W; Hodges J; Kass PH; Vilches-Moure JG; McElliot V; Moore PF
Vet Pathol; 2013 Mar; 50(2):281-90. PubMed ID: 22711745
[TBL] [Abstract][Full Text] [Related]
12. LOPP chemotherapy as a first-line treatment for dogs with T-cell lymphoma.
Brown PM; Tzannes S; Nguyen S; White J; Langova V
Vet Comp Oncol; 2018 Mar; 16(1):108-113. PubMed ID: 28508557
[TBL] [Abstract][Full Text] [Related]
13. Canine T-zone lymphoma: unique immunophenotypic features, outcome, and population characteristics.
Seelig DM; Avery P; Webb T; Yoshimoto J; Bromberek J; Ehrhart EJ; Avery AC
J Vet Intern Med; 2014; 28(3):878-86. PubMed ID: 24655022
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of the updated Kiel classification in canine high-grade T-cell lymphomas.
Jankowska U; Jagielski D; Czopowicz M; Sapierzyński R
Vet Med Sci; 2024 Jul; 10(4):e1398. PubMed ID: 38767567
[TBL] [Abstract][Full Text] [Related]
15. Specific immunotypes of canine T cell lymphoma are associated with different outcomes.
Deravi N; Berke O; Woods JP; Bienzle D
Vet Immunol Immunopathol; 2017 Sep; 191():5-13. PubMed ID: 28895866
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of single-agent mitoxantrone as chemotherapy for relapsing canine lymphoma.
Lucroy MD; Phillips BS; Kraegel SA; Simonson ER; Madewell BR
J Vet Intern Med; 1998; 12(5):325-9. PubMed ID: 9773407
[TBL] [Abstract][Full Text] [Related]
17. The animal-dependent risk factors in canine T-cell lymphomas.
Jankowska U; Jagielski D; Czopowicz M; Sapierzyński R
Vet Comp Oncol; 2017 Jun; 15(2):307-314. PubMed ID: 26300427
[TBL] [Abstract][Full Text] [Related]
18. Gamma delta T-cell large granular lymphocyte lymphoma in a dog.
Ortiz AL; Carvalho S; Leo C; Riondato F; Archer J; Cian F
Vet Clin Pathol; 2015 Sep; 44(3):442-7. PubMed ID: 25965815
[TBL] [Abstract][Full Text] [Related]
19. Canine nodal marginal zone lymphoma: Descriptive insight into the biological behaviour.
Cozzi M; Marconato L; Martini V; Aresu L; Riondato F; Rossi F; Stefanello D; Comazzi S
Vet Comp Oncol; 2018 Jun; 16(2):246-252. PubMed ID: 29205839
[TBL] [Abstract][Full Text] [Related]
20. Response rate after administration of a single dose of doxorubicin in dogs with B-cell or T-cell lymphoma: 41 cases (2006-2008).
Beaver LM; Strottner G; Klein MK
J Am Vet Med Assoc; 2010 Nov; 237(9):1052-5. PubMed ID: 21034344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
